1
|
Kabala JE: The kidneys and ureters.
Textbook of Radiology and Imaging. Sutton D: (London). Churchill
Livingstone. 9532003.
|
2
|
Lopez-Beltran A, Scarpelli M, Montironi R
and Kirkali Z: 2004 WHO classification of the renal tumors of the
adults. Eur Urol. 49:798–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Li XF, Zhou FJ, Qiu SP, et al: Diagnosis
and treatment of renal cell carcinoma with vena cava tumor thrombi.
Ai Zheng. 23:1074–1067. 2004.(In Chinese). PubMed/NCBI
|
4
|
Cost NG, Delacroix SE Jr, Sleeper JP,
Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ,
Brugarolas J, et al: The impact of targeted molecular therapies on
the level of renal cell carcinoma vena caval tumor thrombus. Eur
Urol. 59:912–918. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Choueiri TK, Mosquera JM and Hirsch MS: A
case of adult metastatic Xp11 translocation renal cell carcinoma
treated successfully with sunitinib. Clin Genitourin Cancer.
7:E93–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Malouf GG, Camparo P, Oudard S, et al:
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion
renal cell carcinoma (RCC): A report from the Juvenile RCC Network.
Ann Oncol. 21:1834–1838. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Neves RJ and Zincke H: Surgical treatment
of renal cancer with vena cava extension. Br J Urol. 59:390–395.
1987. View Article : Google Scholar : PubMed/NCBI
|
8
|
Guo HF, Song Y and Na YQ: Value of
abdominal ultrasound scan, CT and MRI for diagnosing inferior vena
cava tumour thrombus in renal cell carcinoma. Chin Med J (Engl).
122:2299–2302. 2009.PubMed/NCBI
|
9
|
Chiappini B, Savini C, Marinelli G, Suarez
SM, Di Eusanio M, Fiorani V and Pierangeli A: Cavoatrial tumor
thrombus: Single-stage surgical approach with profound hypothermia
and circulatory arrest, including a review of the literature. J
Thorac Cardiovasc Surg. 124:684–688. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Paul JG, Rhodes MB and Skow JR: Renal cell
carcinoma presenting as right atrial tumor with successful removal
using cardiopulmonary bypass. Ann Surg. 181:471–473. 1975.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Argani P, Hicks J, De Marzo AM, Albadine
R, Illei PB, Ladanyi M, Reuter VE and Netto GJ: Xp11 translocation
renal cell carcinoma (RCC): Extended immunohistochemical profile
emphasizing novel RCC markers. Am J Surg Pathol. 34:1295–1303.
2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Argani P and Ladanyi M: The evolving story
of renal translocation carcinomas. Am J Clin Pathol. 126:332–334.
2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Argani P, Lal P, Hutchinson B, Lui LY,
Reuter VE and Ladanyi M: Aberrant nuclear immunoreactivity for TFE3
in neoplasms with TFE3 gene fusions: A sensitive and specific
immunohistochemical assay. Am J Surg Pathol. 27:750–761. 2003.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu Y, Xu B and Chen F: Recent advances in
renal cell carcinoma associated with Xp11.2 translocations/TFE gene
fusions. N Am J Med Sci. 5:43–47. 2012. View Article : Google Scholar
|
15
|
Klatte T, Streubel B, Wrba F, Remzi M,
Krammer B, de Martino M, Waldert M, Marberger M, Susani M and
Haitel A: Renal cell carcinoma associated with transcription factor
E3 expression and Xp11.2 translocation: Incidence, characteristics,
and prognosis. Am J Clin Pathol. 137:761–768. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kuroda N, Katto K, Tanaka Y, Yamaguchi T,
Inoue K, Ohara M, Mizuno K, Hes O, Michal M and Lee GH: Diagnostic
pitfall on the histological spectrum of adult-onset renal carcinoma
associated with Xp11.2 translocations/TFE3 gene fusions. Med Mol
Morphol. 43:86–90. 2010. View Article : Google Scholar : PubMed/NCBI
|